Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces First Patient Screened in the Whistler Phase 3b Trial of NCX 470 in Glaucoma

December 18, 2023

View Press Release Corporate presentation Contact us
Previous